PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) AND WEEKLY PACLITAXEL (T) AS FIRST-LINE TREATMENT IN METASTATIC BREAST CANCER (MBC)

被引：0
|
作者：
Badalamenti, Giuseppe [1 ]
Valerio, Maria Rosaria [1 ]
Rinaldi, Gaetana [1 ]
Arcara, Carlo [1 ]
Cicero, Giuseppe [1 ]
Vizzini, Laura [1 ]
Travagliato, Maria Grazia [1 ]
Intrivici, Chiara [1 ]
Russo, Antonio [1 ]
Gulotta, Gaspare [1 ]
Gebbia, Nicola [1 ]
Fulfaro, Fabio [1 ]
机构：
[1] Univ Palermo, Dept Oncol, Palermo, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [1] Weekly paclitaxel (T) and pegylated liposomal doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.
    Fulfaro, F
    Valerio, MR
    Badalamenti, G
    Arcara, C
    Cicero, G
    Intrivici, C
    Crosta, A
    Sciortino, C
    Russo, A
    Gebbia, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 53S - 53S
  • [2] Weekly paclitaxel and pegylated liposomal doxorubicin (PLD) as first-line therapy in metastatic breast cancer
    Valerio, M. R.
    Fulfaro, F.
    Cicero, G.
    Rinaldi, G.
    Maiorana, O.
    Spinnato, F.
    Intrivici, C.
    Crosta, A.
    Scibilia, C.
    Pizzo, T.
    Vanella, P.
    Gebbia, N.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII147 - VII147
  • [3] Pegylated liposomal doxorubicin (PLD) and weekly paclitaxel as first line therapy in metastatic breast cancer
    Fulfaro, F.
    Valerio, M. R.
    Cicero, G.
    Rinaldi, G.
    Intrivici, C.
    Pizzo, T.
    Crosta, A.
    Scibilia, C.
    Gebbia, N.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI10 - XI11
  • [4] Pilot study with pegylated liposomal doxorubicin (PLD) and docetaxel as first-line treatment in patients with metastatic breast cancer (MBC)
    Mel, J. R., Sr.
    Ramos, M.
    Cueva, J.
    Castellanos, J.
    Almanza, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] TOXICITY OF WEEKLY LIPOSOMAL DOXORUBICIN AND PACLITAXEL IN METASTATIC BREAST CANCER (MBC)
    Longo, F.
    Pellegrini, P.
    Ceccarelli, F.
    Borgomastro, A.
    Comito, T.
    Basile, M. L.
    De Biasio, G.
    Girolami, M.
    Spalletta, B.
    Di Seri, M.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 23 - 23
  • [6] Phase I-II study of pegylated liposomal doxorubicin combined with weekly paclitaxel as first-line treatment in patients with metastatic breast cancer
    Bourgeois, Hugues
    Ferru, Aurelie
    Lortholary, Alain
    Delozier, Thierry
    Boisdron-Celle, Michelle
    Abadie-Lacourtoisie, Sophie
    Joly, Florence
    Chieze, Stephanie
    Chabrun, Virginie
    Gamelin, Erick
    Tourani, Jean-Marc
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (03): : 267 - 275
  • [7] Phase I/II Gemcitabine (G) with Pegylated Liposomal Doxorubicin (PLD) as first-line therapy in metastatic breast cancer (MBC) in Asian women
    Wong, Zee Wan
    Shah, Valencia A.
    Wong, Nan Soon
    Ang, Peter Cher Siang
    Silverman, Carrie
    Tan, Say Beng
    Cheung, Yin Bun
    Chowbay, Balram
    See, Hui Ti
    Khoo, Kei Siong
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 43 - 43
  • [8] Weekly paclitaxel, doxorubicin, and carboplatin in the first-line treatment of patients with metastatic breast cancer
    Hainsworth, JD
    Burris, HA
    Greco, FA
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (06) : 13 - 13
  • [9] Weekly paclitaxel and pegylated liposomal doxorubicin in metastatic breast carcinoma
    Leonardi, V.
    Palmisano, V.
    Pepe, A.
    Usset, A.
    Savio, G.
    Laudani, A.
    Calabria, C.
    Tartaglia, L.
    Amari, P.
    Carruba, G.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 55 - 55
  • [10] Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
    Schwonzen, M
    Kurbacher, CM
    Mallmann, P
    [J]. ANTI-CANCER DRUGS, 2000, 11 (09) : 681 - 685
12345